Vitamin D3 supplementation in adult patients with non-cystic fibrosis bronchiectasis - a feasibility study

Not Applicable

Completed

• Conditions: Bronchiectasis; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12612001222831
• Lead Sponsor: Middlemore Clinical Trials

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-11-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients with a diagnosis of bronchiectasis based on high resolution chest CT scan within the previous 2 years

Exclusion Criteria

Patients taking Vitamin D3 supplement >600iu per day, patients with cystic fibrosis

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess the range of 25(OH) D levels in adult patients with non-cystic fibrosis bronchiectasis and whether vitamin D3 supplementation increases 25(OH) D levels above 75 nmol/L.<br>Serum samples will be collected at baseline, week 13 and week 26 (end of study) for analysis[Baseline, week 13 and week 26]